Autosomal dominant tubulointerstitial kidney disease due to UMOD mutations

How is autosomal dominant tubulointerstitial kidney disease due to UMOD mutations (ADTKD-UMOD) diagnosed?

The diagnosis of autosomal dominant tubulointerstitial kidney disease due to UMOD mutations (ADTKD-UMOD) is made based on the symptoms, specific laboratory tests, a family history of kidney disease and gout, and genetic testing.

Last updated on 05-01-20

How is autosomal dominant tubulointerstitial kidney disease due to UMOD mutations (ADTKD-UMOD) inherited?

Autosomal dominant tubulointerstitial kidney disease due to UMOD mutations (ADTKD-UMOD) is inherited in an autosomal dominant pattern. All individuals inherit two copies of each gene. In autosomal dominant conditions, having a mutation in just one copy of the associated ( UMOD ) gene causes the person to have the disease. Some people are born with an autosomal dominant condition due to a new genetic mutation (de novo) and do not have a history of this condition in their family. There is nothing either parent can do, before or during pregnancy, to cause a child to have this.

Each child of an individual with ADTKD-UMOD has a 50% or 1 in 2 chance of inheriting the UMOD mutation and ADTKD-UMOD. Children who inherit the UMOD mutation will have ADTKD-UMOD, although they could be more or less severely affected than their parent.

Last updated on 05-01-20

What is the long-term outlook for people with autosomal dominant tubulointerstitial kidney disease due to UMOD (ADTKD-UMOD)?

The long-term outlook for people with autosomal dominant tubulointerstitial kidney disease due to UMOD mutations is good, though patients will often need a kidney transplant or start dialysis between the ages of 30 and 70. At this point, it is difficult to predict at what age patients will develop end- stage kidney failure.

Last updated on 05-01-20

How many people have autosomal dominant tubulointerstitial kidney disease due to UMOD mutations (ADTKD-UMOD)?

The exact prevalence of autosomal dominant tubulointerstitial kidney disease due to UMOD mutations (ADTKD-UMOD) is unknown. One study found the prevalence in Austria to be about 1-2 cases per million people. Less than 1% of people with kidney disease have ADTKD-UMOD.

Last updated on 05-01-20

How might autosomal dominant tubulointerstitial kidney disease due to UMOD mutations (ADTKD-UMOD) be treated?

Treatment for autosomal dominant tubulointerstitial kidney disease due to UMOD mutations (ADTKD-UMOD) is based on managing the symptoms. Gout can be prevented with medications such as allopurinol and febuxostat. At present, there are no specific treatments for worsening kidney function. Eventually, patients may need a kidney transplant or dialysis. Live donor kidney transplantation is the optimal treatment for worsening kidney disease, and patients who undergo kidney transplant for this condition do extremely well. The condition does not come back in the transplanted kidney.

Last updated on 05-01-20

Name: National Kidney Foundation 30 East 33rd Street
New York, NY, 10016, United States
Phone: 212-889-2210 Toll Free: 800-622-9010 Fax : 212-689-9261 Email: info@kidney.org Url: https://www.kidney.org/
Name: American Association of Kidney Patients 3505 E. Frontage Rd., Suite 315
Tampa, FL, 33607-1796, United States
Phone: 813-636-8100 Toll Free: 800-749-2257 Fax : 813-636-8122 Email: info@aakp.org Url: http://www.aakp.org
Name: The Kidney Foundation of Canada 700-15 Gervais Drive Toronto Ontario M3C 1Y8
Canada
Phone: 416-445-0373 Toll Free: 800-387-4474 Fax : 416-445-7440 Email: kidney@kidney.on.ca Url: http://www.kidney.on.ca
Name: American Kidney Fund, Inc. 6110 Executive Boulevard Suite 1010
Rockville, MD, 20852, United States
Phone: 301-881-3052 Toll Free: 866-300-2900 Email: helpline@kidneyfund.org Url: http://www.kidneyfund.org
Name: UKD Foundation 425 Madison Ave, 9th Floor
New York, NY, 10017, United States
Phone: 828-738-5301 Email: http://www.ukdcure.org/contact Url: http://www.ukdcure.org/
Name: Rare Inherited Kidney Disease Team Wake Forest School of Medicine Medical Center Boulevard
Winston-Salem, NC, 27157,
Email: kidney@wakehealth.edu
Name: Wake Forest School of Medicine Rare Inherited Kidney Disease Team Medical Center Blvd.
Winston-Salem, NC, 27157,
Email: kidney@wakehealth.edu
Eckardt KU, Alper SL, Antignac C, Bleyer AJ, Chauveau D, Dahan K, Deltas C, Hosking A, Kmoch S, Rampoldi L, Wiesener M, Wolf MT, Devuyst O. Kidney Disease: Improving Global Outcomes. Autosomal dominant tubulointerstitial kidney disease: diagnosis, classification, and management-A KDIGO consensus report Kidney Int. Oct 2015; 88(4). 676-683. Reference Link Devuyst O, Olinger E, Rampoldi L. Uromodulin: from physiology to rare and complex kidney disorders. Nat Rev Nephrol. Sep 2017; 13(9). 525-544. Reference Link

Note, these links are external searches against the National Laboratory of Medicine's drug database. You may need to adjust the search if there are no results found.

Drug Name Generic Name
Jynarque tolvaptan

Connect with other users with Autosomal dominant tubulointerstitial kidney disease due to UMOD mutations on the RareGuru app

Do you have information about a disease, disorder, or syndrome? Want to suggest a symptom?
Please send suggestions to RareGuru!

The RareGuru disease database is regularly updated using data generously provided by GARD, the United States Genetic and Rare Disease Information Center.

People Using the App

Join the RareGuru Community

To connect, share, empower and heal today.

People Using the App